An interventional study of FTTN: From There Towards Now in Anxiety Disorders and Symptoms, Depressive Disorder and Personality Disorders, sponsored by Arkin. Recruiting at 2 sites in Netherlands. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by Arkin · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 70 studies in Anxiety Disorders with a site in Netherlands — 19 open to participants now, 22 under way, none of them phase 3. Anxiety Disorders · Netherlands.
Among the 70 studies in Anxiety Disorders with a site in Netherlands, this one is the 54th largest by planned enrollment of the 60 interventional ones that give a count, is one of 6 that started in 2025, is one of 52 with no phase, reaches primary completion later than 19 of the 21 other live ones, and was the 36th registered.
7,249 studies on the registry are indexed under Anxiety Disorders; 1,691 are open to participants now.
Browse Anxiety Disorders studies →19 of the 70 studies in Anxiety Disorders with a site in Netherlands are open now. Recruiting first, the newest first:
Luuk Stapersma · Sites in Netherlands
Ages 4–13
Radboud University Medical Center · Sites in Netherlands
Ages 18+
VU University of Amsterdam · Sites in Netherlands
Ages 18+
ProPersona · Sites in Netherlands
Ages 65+
Tilburg University · Sites in Netherlands, Greece
Ages 18+ · Healthy volunteers
A study can be open while its sites in Netherlands have not opened yet or have stopped. Only those recruiting at a site in Netherlands →
Of the 947 Anxiety Disorders studies recruiting now, 423 (45%) set no upper age limit and 455 (48%) stop at 75 or younger; 233 take children under 18; 319 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
70 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 1 · Phase 3 3 · Phase 4 2
First in 2001; this study’s year is marked. 6 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 80 across 6,103 interventional studies indexed under Anxiety Disorders.
Median enrollment 156 across the 60 interventional studies, 560 across the 10 observational. Of the 44 that completed or were terminated, 2 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 70 have an industry lead sponsor. The 10 most frequent:
Arkin is the lead sponsor of 7 studies on the registry; 4 are open to participants now.
Arkin has 1 study filed under Anxiety Disorders — fewer than ten, so there is no comparison to draw.
6 of the studies in Anxiety Disorders with a site in Netherlands that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05942391Amsterdam UMC, location VUmcBrief-intensive CBT Versus Once-weekly CBT in Anxiety-related Disorders | 2026-11 |
| NCT07022184Radboud University Medical CenterLifestyle Intervention for Symptoms of Depression wIth App Support in General Practice | 2026-11 |
| NCT06979089VU University of AmsterdamImplementation of WHO's Doing What Matters in Times of Stress in Dutch Small and Medium-sized Enterprises (SMEs) | 2027-03 |
| NCT06882629Luuk StapersmaVR Homework Exercises for Selective Mutism Treatment | 2027-04 |
| NCT07950800ArkinFrom There Towards Now; Intervention for Jewish and Indonesian Post-war Generations | 2027-08-01 |
Add all 6 to your calendar (.ics) → With an account.
Among the 70 studies in Anxiety Disorders with a site in Netherlands, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this open pilot study is to learn whether FTTN is effective in treating mental health problems in adult children of World War 2-survivors, who attribute their symptoms of anxiety, mood and/or personality problems to their parents' war trauma.
Participants will:
The Children of Parents with Mental Illnesss following Trauma, here called COPMI-T, often display anxiety, mood and personality symptoms, which they attribute to the trauma history of their parents. Guideline interventions for anxiety, mood and personality disorders often offer little room for addressing that specific context. Based on years of experience with the Jewish and Indonesian post-war generation of the Second World War, a new therapy method 'From There Towards Now' (FTTN or VDNN) was developed in the Sinai Center and applied to adult COPMI-T.
Brief description of FTTN:
1) the home situation with traumatized educators is concisely symbolized in an emotionally corrective setting with a therapist; 2) the parents have woven destructive conclusions from the context of their traumatization into the upbringing. This interferes with their children's healthy emotional development. In the therapy, these (now adult) KOPP-T children are helped to recognize, investigate and ultimately reject this transgenerational phenomenon in their upbringing; 3) the KOPP-T children are proposed to distance themselves from those parent-child relational codes that are associated with the traumatization of the parents; 4) KOPP-T children are encouraged to detach from the parents and to attach their own meanings to the traumatization of the parents. This promotes the construction of a healthy and meaningful existence.
The FTTN intervention consists of 4 individual sessions of 75 minutes during approximately 2 months, plus a follow-up session after 2 months with one family member. Dolls and time screens are used to symbolize the memories and to non-verbally express the process of separation.
The aim of this pilot study is to explore whether the intervention 'From There Towards Now' is effective in reducing anxiety and mood (OQ-45), obsessive-compulsive (Y-BOCS), PTSD (PCL- 5) and personality symptoms (SIPP-SF), next to quality of life (EQ-5D-5L), interpersonal functioning (RSQ/CPI), and the relationship with the war-affected parent(s) (measured with a qualitative interview). The study concerns an open pilot study, in which the effectiveness of FTNN is tested in COPMI-T, who are being treated or will be treated at the outpatient clinic of the Sinai Center.
The study has 3 measurement points (Baseline (T0): start of the intervention, 2 months later (T1): end of the intervention, and follow-up: 2 months after T1). The risk of this study has been assessed as 'negligible'. During the intervention there may be perceived emotional distress in the form of feelings of disappointment, anger and sadness. These are common in psychotherapy, and also necessary to accomplish change. Working with trained therapists and excluding specific vulnerable subgroups (e.g., ASD, psychosis, mental disability) from participation, ensures that participants' distress remains manageable and ultimately leads to a better emotional equilibrium. This estimate is based on experience with this method, which has been developed and described in the last 10 years.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Pre-post design
Behavioral: FTTN: From There Towards Now
The FTTN intervention consists of 4 individual sessions of 75 minutes during approximately 2 months, plus a follow-up session after 2 months with one family member. Dolls and time screens are used to symbolize the memories and to non-verbally express the process of separation.
Change in Outcome Questionnaire-45 (OQ-45)
General psychological symptoms, including anxiety and mood symptoms. Range: 0-180 Higher score = more severe symptoms ( = worse)
Time frame: Baseline (T0), 2 months (T1), 4 months (T2)
Change in Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
Obsessive compulsive symptoms. Range = 0-50. Higher score = more severe symptoms ( = worse).
Time frame: Baseline (T0), 2 months (T1), 4 months (T2)
Change in PTSD Symptom checklist for the DSM-5 (PCL-5)
PTSD symptoms. Range: 0-80. Higher score = more severe symptoms ( = worse).
Time frame: Baseline (T0), 2 months (T1), 4 months (T2)
Change in Severity Index of Personality Problems (SIPP-SF).
Personality problems. Range: 0-240. Higher score = better functioning ( = better).
Time frame: Baseline (T0), 2 months (T1), 4 months (T2)
Change in EuroQol 5-Dimension 5-Level (EQ-5D-5L)
Quality of life. Range: 5-25. Higher scores = more severe problems and/or problems on more different life domains ( = worse).
Time frame: Baseline (T0), 2 months (T1), 4 months (T2)
Change in CPI (Close Person Inventory)
Interpersonal functioning. Range: 10-50 per subscale. Higher scores = more social support ( = better) (some items will be recoded because they are reversed: higher score = less support).
Time frame: Baseline (T0), 2 months (T1), 4 months (T2).
Change in Relationship Scale Questionnaire (RSQ)
Attachment. Range: 15-75 per dimension (Model of Self and Model of Other). Higher scores on each dimension = More secure ( = better) (some items will be recoded because they are reversed: higher score = less secure).
Time frame: Baseline (T0), 2 months (T1), 4 months (T2).
Change in insight into illness/attribution and relationship with parents
Qualitative interview
Time frame: Baseline (T0) and 4 months (T2)
Childhood Trauma Questionnaire (CTQ)
Childhood Trauma. Range: 5-25 per subscale (emotional abuse, physical abuse, sexual abuse, emotional neglect, physical neglect). Higher score = more severe childhood trauma ( = worse).
Time frame: Baseline (T0)
Life Events Questionnaire for DSM-5 (LEC-5)
Life Events. Range = LEC-5 contains 17 events, but participants may report more than one type of exposure to each event (e.g., experienced personally and witnessed it happening to someone else). Higher score = more life events (does not measure severity/intensity).
Time frame: Baseline (T0)
Plan to share: No
Started Apr 2025 (actual). Primary completion is estimated for Aug 2027, 28 months after the start.
Of 105 industry-sponsored interventional studies with no phase under Anxiety Disorders, half reached primary completion within 6 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 16. This study's planned 28 months is above that.
Counting every sponsor, half of 3,976 studies reached it within 12 months; a quarter within 5 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Arkin